SCO-8 Controverses en chirurgie réfractive

Gestion des cas défis et de la presbytie

Le jeudi 28 juin 2012, 1545-1715
Metro West

Objectifs
À la fin de la session, les participants pourront :

  • Intégrer le savoir des nouveaux développements dans la chirurgie de la presbytie.
  • Démontrer une capacité améliorée de gérer les cas défis de la chirurgie réfractive.
  • Comparer les différentes façons de gérer la presbytie.


Invité
Ronald R. Krueger, MD, MSE
Animateurs
Rusty Ritenour
George Beiko

1545Welcome and introductions
1550Does modified Micro-Monovision correct presbyopia?
Christoph Kranemann, Marcelo Stevenson
1556Hyperopic photorefractive keratectomy versus myopic photorefractive keratectomy post laser-assisted in situ keratomileusis
Stephanie A. Low, Alfonso Iovieno, Dan Rootman, Sonia N. Yeung, Alejandro Lichtinger, David S. Rootman
1602Mirror symmetry of the right and left eyes 3D corneal shape
Georges M. Durr, Edouard Auvinet, Jeb A. Ong, Marina Gilca, Marie-Eve Choronzey, Jean Meunier, Isabelle Brunette
1608Discussion
1630Adaptive optics visual simulation for expanding depth of focus in presbyopia
Ronald R. Krueger
1637Discussion
1640Propsective evalution of the small aperture corneal inlay for the treatment of emmetropic presbyopia
Gary Foster
1646Discussion
1647Is there a difference in outcome of femtosecond assisted LASIK performed by cornea fellows compared with that of experienced staff surgeons?
Rachel Wolff, Alejandro Lichtinger, Uri Elbaz, Judy Y. Ku, Sonia N. Yeung, Peter Kim, Allan R. Slomovic, David S. Rootman
1653Is topography-guided photorefractive keratectomy for keratoconus with simultaneous collagen cross-linking using the IVIS laser effective?
Simon Holland, David Lin
1659Is topography-guided photorefractive keratectomy (TG-PRK) with simultaneous collagen cross-linking for post LASIK ectasia using iVIS and Allegretto effective?
Simon Holland, David Lin
1705Topography-guided ablation for optical zone enlargement and correction of decentered ablations
Tenley N. Bower, Eser Adiguzel, Mark Cohen, Avi Wallerstein
1711Discussion
1715Closing remarks


Ronald R. Krueger, MD, MSE